<code id='81F8FFF711'></code><style id='81F8FFF711'></style>

<acronym id='81F8FFF711'></acronym>

<center id='81F8FFF711'><center id='81F8FFF711'><tfoot id='81F8FFF711'></tfoot></center><abbr id='81F8FFF711'><dir id='81F8FFF711'><tfoot id='81F8FFF711'></tfoot><noframes id='81F8FFF711'>

<optgroup id='81F8FFF711'><strike id='81F8FFF711'><sup id='81F8FFF711'></sup></strike><code id='81F8FFF711'></code></optgroup>

<b id='81F8FFF711'><label id='81F8FFF711'><select id='81F8FFF711'><dt id='81F8FFF711'><span id='81F8FFF711'></span></dt></select></label></b><u id='81F8FFF711'></u>

~~<i id='81F8FFF711'><strike id='81F8FFF711'><tt id='81F8FFF711'><pre id='81F8FFF711'></pre></tt></strike></i>~~

Home» Wikipedia» explore

explore

explore

author：Wikipedia 2025-10-04 10:22:43 Page View：323

HHS 2020 — PhRMA is suing the Biden administration over its new Medicare drug price negotiation program. Graeme Sloan/Sipa USA

WASHINGTON — After losing the drug pricing fight on Capitol Hill, PhRMA is taking its battle to the courts.

The pharmaceutical industry’s biggest lobbying group on Wednesday filed a long-expected lawsuit challenging Democrats’ drug pricing law that allowed Medicare to start negotiating prices for certain medicines.

advertisement

PhRMA joins a growing club of companies and trades challenging the law. Merck, Bristol Myers Squibb, and the Chamber of Commerce have already filed similar suits in different courts.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Cheesesteak restaurant owner explains his secret sauce, the viral Malibu Barbie Dream Drizzle
Next article： Cancer drug shortages should be causing more outrage

comprehensive

Novavax promises a turnaround & Lilly roils the obesity market

SammyKimballforSTATCanNovavaxfinallygetitright?What’sa“triple-G”drug?AndisNovoNordisklosingground?We

Primary care physicians play key roles in Alzheimer's management

Primary care physicians play key roles in Alzheimer's management

AdobeWhentheresultsofPresidentBiden’sannualphysicalwerereleasedlastmonth,manywonderedwhyhisprimaryca

Medicare proposal to cover medical devices draws a mixed reaction

Medicare proposal to cover medical devices draws a mixed reaction

AdobeThemedicaldeviceindustryissplitonwhetheraproposednewMedicarereimbursementpathwaywilldoanythingt

The Readout: Lenmeldy, GLP

AdobeTodayistheinauguralpublishingdayforAdam’sBiotechScorecard—asubscriber-onlynewsletterofferingsen

read more